25 Jan'21 - KRX disclosure - Ag test supply order via US distro (Intrivo Diagnostics) for US$70m
http://dart.fss.or.kr/dsaf001/main.do?rcpNo=20210125900130
Looking at Access Bio's past 3-4 yr financials - this seems to be the largest sales rev order in its corporate history....
That's totalling a stupendous ~US$134m revenue gain (since Oct'20) + whatever Ginkgo Bioworks agreed to for its 10m kit order.
25 Jan'21 - KRX disclosure - Ag test supply order via US distro...
-
- There are more pages in this discussion • 1,803 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AT1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.34M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 497908 | 2.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.5¢ | 67200 | 3 |
View Market Depth
| Last trade - 16.12pm 02/08/2024 (20 minute delay) ? |
| AT1 (ASX) Chart |
Day chart unavailable